azathioprine has been researched along with Jaw Diseases in 2 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Jaw Diseases: Diseases involving the JAW.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rees, J | 1 |
Paterson, AW | 1 |
Westbrook, SD | 1 |
2 other studies available for azathioprine and Jaw Diseases
Article | Year |
---|---|
Langerhans cell histiocytosis in an adult.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Facial Pain; Histiocytosis, Langerhans | 2009 |
Dental management of patients receiving hemodialysis and kidney transplants.
Topics: Anti-Bacterial Agents; Azathioprine; Dental Calculus; Dental Care; Humans; Jaw Diseases; Kidney Dise | 1978 |